Kenvue Inc.

KVUE • Household & Personal Products

$18.74

▼ -0.21 (-1.11%)

Precio actual

ResultadosÚltimo reporte: 28 jun 2026

PERFIL FAVORABLEAtractivaConfianza: 70%

Perfil cuantitativo — no constituye una recomendación de inversión.

Perfil cuantitativo — no constituye una recomendación de inversión.Metodología

Tesis del análisis: Alta calidad del negocio, con crecimiento y flujo de caja que respaldan el caso. La valoración todavía importa, pero el historial de ratios es favorable.

Capitalización

$36.02B

Crecimiento

0.7%

Flujo de caja

5/5

Tendencia

Stable

Evidencia

Márgenes estables o en mejora · 9.7%Flujo de caja libre positivo · 0.9Flujo de caja libre consistente · 5/5Nivel de deuda manejable · 0.79Liquidez débil · 0.96

Datos financieros hasta: 28 jun 2026, 12:00 a.m. UTCÚltima actualización de earnings: 28 jun 2026, 12:00 a.m. UTCÚltima actualización del perfil: 7 ago 2026, 12:18 p.m. UTC

Resumen de la compañía

Valoración, calidad, fortaleza financiera, momentum y datos de analistas.

Price$18.74

Change-1.11%

Shares Out1.92B

Market Cap$36.02B

Enterprise Value$43.39B

52W Range14.02 - 21.96

Beta0.44

P/E21.72

P/S2.34

P/B3.41

P/FCF25.45

EV/Sales2.82

Price$18.74

Change-1.11%

Shares Out1.92B

Market Cap$36.02B

Enterprise Value$43.39B

52W Range14.02 - 21.96

Beta0.44

P/E21.72

P/S2.34

P/B3.41

P/FCF25.45

EV/Sales2.82

EV/EBITDA14.63

EV/FCF30.65

Earnings Yield4.60%

FCF Yield3.93%

Dividend Yield5.51%

Gross Margin58.13%

Oper. Margin17.88%

Profit Margin9.72%

Debt/Eq0.79

Current Ratio0.96

Quick Ratio0.68

Revenue 5Y0.66%

FCF 5Y-7.50%

Target$19.50

Target Upside4.06%

Target Median$19.50

Target Range19.00 - 20.00

Volume17.45M

Avg Volume20.04M

EPS Surprise0.06

ADN de inversión

Qué tan fuerte luce esta compañía para inversionistas de largo plazo

de 100

Calidad del negocio

Márgenes, ventaja competitiva, retornos

70/100

Fortaleza financiera

Deuda, caja, estabilidad

54/100

Potencial de crecimiento

Ingresos y expansión

58/100

Atractivo del precio

Barata o cara hoy

73/100

Por qué este puntaje▼

Márgenes estables o en mejora · 9.7%Flujo de caja libre positivo · 0.9Flujo de caja libre consistente · 5/5Nivel de deuda manejable · 0.79Liquidez débil · 0.96

Analyst view

Analyst sentiment and price target

KVUE

Analyst sentiment

Based on 14 analyst votes · 2026-09-05

64/100

Neutral

Bullish

Hold

Bearish

Precio objetivo

2026-08-07

Bajo

$18.00

Promedio

$19.00

Mediana

$19.00

Alto

$20.00

Resumen de la compañía

IPO: 5/4/2023

Industria: Household & Personal Products

P/B i: 3.41

Deuda / Patrimonio i: 0.79

Margen operativo: 17.88%

Margen neto: 9.72%

ROE i: -

ROIC: -

Salud financiera

Puntaje11 / 20

Deuda / Patrimonio: 0.79

Ratio corriente: 0.96

Ratio rápido: 0.68

Estado: Moderate

Advertencias

Weak Liquidity
Weak quick ratio

Transacciones internas

Actividad reciente de ejecutivos e insiders

Dasgupta Anindya

Transacción: 07/31/2026

COMPRA

Cambio

—

Precio

Not reported

Presentación

08/04/2026

Tipo

COMPRA

Dasgupta Anindya

Transacción: 07/31/2026

VENTA

Cambio

—

Precio

Not reported

Presentación

08/04/2026

Tipo

VENTA

ALLISON RICHARD E JR

Transacción: 06/29/2026

COMPRA

Cambio

+1,413

Precio

Not reported

Presentación

07/01/2026

Tipo

COMPRA

Insider	Tipo	Cambio	Precio	Transacción	Presentación
Dasgupta Anindya	COMPRA	—	Not reported	07/31/2026	08/04/2026
Dasgupta Anindya	VENTA	—	Not reported	07/31/2026	08/04/2026
ALLISON RICHARD E JR	COMPRA	+1,413	Not reported	06/29/2026	07/01/2026
Smith Jeffrey C	COMPRA	+1,413	Not reported	06/29/2026	07/01/2026
Howlett Heather	VENTA	-3,700	$18.11	06/10/2026	06/12/2026
Godbole Seemantini	COMPRA	+10,309	Not reported	05/21/2026	05/26/2026
Mann Erica L	COMPRA	+10,309	Not reported	05/21/2026	05/26/2026
ALLISON RICHARD E JR	COMPRA	+10,309	Not reported	05/21/2026	05/26/2026
PAWLUS KATHLEEN M	COMPRA	+10,309	Not reported	05/21/2026	05/26/2026
Healey Melanie	COMPRA	+10,309	Not reported	05/21/2026	05/26/2026
Sneed Michael E	COMPRA	+10,309	Not reported	05/21/2026	05/26/2026
PRABHU VASANT M	COMPRA	+10,309	Not reported	05/21/2026	05/26/2026
MERLO LARRY J	COMPRA	+16,036	Not reported	05/21/2026	05/26/2026
HOLDEN BETSY D	COMPRA	+10,309	Not reported	05/21/2026	05/26/2026
Hofstetter Sarah	COMPRA	+10,309	Not reported	05/21/2026	05/26/2026
Smith Jeffrey C	COMPRA	+10,309	Not reported	05/21/2026	05/26/2026
Curado Gomes de Lemos Leonardo	VENTA	-7,141	$17.43	05/01/2026	05/26/2026
Curado Gomes de Lemos Leonardo	VENTA	—	Not reported	05/01/2026	05/26/2026
Orlando Matthew	VENTA	—	$17.66	05/08/2026	05/12/2026
Smith Jeffrey C	COMPRA	+1,331	Not reported	03/30/2026	04/01/2026

Sobre la compañía

Kenvue Inc.

Kenvue Inc. functions as a global leader in the consumer health sector. The company structures its operations across three primary divisions: Self Care, Skin Health and Beauty, and Essential Health. Within the Self Care unit, it offers a diverse range of products for common conditions like coughs, colds, and allergies, in addition to pain relief, digestive health, and smoking cessation aids, featuring prominent brands such as Tylenol, Nicorette, and Zyrtec. The Skin Health and Beauty segment delivers various solutions for facial, body, hair, and sun protection, recognized under popular labels including Neutrogena, Aveeno, and OGX. Moreover, the Essential Health category provides oral hygiene, infant care, feminine wellness, and wound treatment products, marketed through esteemed brands like Listerine, Johnson's, Band-Aid, and Stayfree. Established in 2022, Kenvue Inc. maintains its corporate headquarters in Skillman, New Jersey, and operates as a subsidiary of Johnson & Johnson.

Fuente - Link

Competidores

ADM CHD EL HSY JBS K KDP KHC KMB SYY

Tamaño = capitalización · color = línea del gráfico

Rendimiento de peers · 1A

Top performers + empresa seleccionada

Ultimas Noticias

Australia clears Kimberly-Clark's acquisition of Kenvue but requires Carefree, Stayfree divestment

Australia's competition regulator on Wednesday approved Kimberly-Clark's proposed $40 billion takeover of Kenvue, on condition the company divests Kenvue's Carefree ‌and Stayfree period care brands in the country to address competition concerns.

Reuters

Kimberly-Clark seeks EU approval for $40 billion Kenvue deal

Kimberly-Clark has asked EU regulators permission for its proposed $40 billion takeover ‌of Tylenol maker Kenvue, documents on the EU Commission's website showed.

Reuters

43,671 Shares in Kenvue Inc. $KVUE Purchased by Callan Family Office LLC

Callan Family Office LLC bought a new position in shares of Kenvue Inc. (NYSE: KVUE) during the quarter, according to its most recent filing with the SEC. The institutional investor bought 43,671 shares of the company's stock, valued at approximately $835,000. A number of other institutional investors have also added to or

Defense World

32,710 Shares in Kenvue Inc. $KVUE Purchased by AssuredPartners Investment Advisors LLC

AssuredPartners Investment Advisors LLC acquired a new position in shares of Kenvue Inc. (NYSE: KVUE) during the quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The institutional investor acquired 32,710 shares of the company's stock, valued at approximately $625,000. A number of other institutional

Defense World

B & T Capital Management DBA Alpha Capital Management Makes New Investment in Kenvue Inc. $KVUE

B and T Capital Management DBA Alpha Capital Management acquired a new stake in shares of Kenvue Inc. (NYSE: KVUE) during the quarter, according to its most recent 13F filing with the SEC. The firm acquired 265,605 shares of the company's stock, valued at approximately $5,076,000. A number of other large investors

Defense World

Sorpresas de ganancias

Período	Estimado	Real	Sorpresa
2026-05-07	0.2621	0.32	0.0579
2026-02-17	0.2227	0.27	0.0473
2025-11-03	0.2602	0.28	0.0198
2025-08-07	0.2817	0.29	0.0083
2025-05-08	0.2275	0.24	0.0125
2025-02-06	0.26	0.26	0
2024-11-07	0.2723	0.28	0.0077
2024-08-06	0.2757	0.32	0.0443
2024-05-07	0.2541	0.28	0.0259
2024-02-08	0.283	0.31	0.027
2023-10-26	0.3	0.31	0.01
2023-07-20	0.29	0.32	0.03